financetom
Business
financetom
/
Business
/
Axsome Therapeutics sleep disorder therapy succeeds in late-stage trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Axsome Therapeutics sleep disorder therapy succeeds in late-stage trial
Mar 25, 2024 3:59 AM

March 25 (Reuters) - Axsome Therapeutics ( AXSM ) said

on Monday its therapy for a sleep disorder met the main goal of

a late-stage study.

(Reporting by Puyaan Singh; Editing by Sriraj Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved